Any two people can use Empathways together. But in the global HIV care, prevention, and treatment community, Jhpiego has leveraged an adapted version of the tool, using it to bring together groups of people who have relationships that are uncomfortable at best, and downright traumatizing at worst.
Continue Reading
For the MOSAIC project team, the AIDS 2022 conference set the stage for embracing the introduction of new biomedical HIV prevention products and generating evidence on how to support choice and effective use. We attended the conference virtually and took away three key messages that resonate with our work on MOSAIC.
Continue Reading
Since oral PrEP was first approved for use in 2012, dozens of countries have approved the product and use is expanding. But the pace of scale-up has been slower than expected and PrEP remains out of reach for many who may benefit from it.
Continue Reading
In this photo story, MOSAIC NextGen Squad representatives introduce themselves through their stories. They share their passions, what led them to work in HIV prevention, their thoughts on MOSAIC, and their hopes and dreams for the future.
Continue Reading
As we move toward a multi-product HIV prevention market, adolescent girls and young women must be empowered to choose an HIV prevention product that meets their needs.
Continue Reading
In the MOSAIC project, the end user—that is, the people who need and/or want to use biomedical HIV prevention (PrEP) products—is at the center of all that we do.
Continue Reading